STRS OHIO - CELLULAR BIOMEDICINE GROUP I ownership

CELLULAR BIOMEDICINE GROUP I's ticker is CBMG and the CUSIP is 15117P102. A total of 35 filers reported holding CELLULAR BIOMEDICINE GROUP I in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
STRS OHIO ownership history of CELLULAR BIOMEDICINE GROUP I
ValueSharesWeighting
Q3 2016$21,000
-44.7%
1,500
-53.1%
0.00%
Q2 2016$38,000
-35.6%
3,2000.0%0.00%
Q1 2016$59,000
-13.2%
3,2000.0%0.00%
Q4 2015$68,000
+25.9%
3,2000.0%0.00%
Q3 2015$54,000
-55.0%
3,2000.0%0.00%
-100.0%
Q2 2015$120,0003,2000.00%
Other shareholders
CELLULAR BIOMEDICINE GROUP I shareholders Q2 2016
NameSharesValueWeighting ↓
PLATINUM INVESTMENT MANAGEMENT LTD 672,885$11,123,0000.26%
AWM Investment Company, Inc. 80,165$1,325,0000.25%
Nikko Asset Management Americas, Inc. 532,318$8,799,0000.17%
ARK Investment Management 314,378$5,197,0000.13%
Sumitomo Mitsui Trust Holdings, Inc. 528,418$8,735,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 32,100$531,0000.01%
Mizuho Securities Co. Ltd. 300$5,0000.01%
GEODE CAPITAL MANAGEMENT, LLC 148,815$2,459,0000.00%
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 18,629$308,0000.00%
STATE OF WISCONSIN INVESTMENT BOARD 16,100$237,0000.00%
View complete list of CELLULAR BIOMEDICINE GROUP I shareholders